HALO
Halozyme Therapeutics Inc.
$77.50
-$0.78(-1.00%)
70
Overall
60
Value
81
Tech
--
Quality
Market Cap
$9.10B
Volume
1.09M
52W Range
$42.01 - $77.95
Target Price
$70.56
EPS Estimates Overview
| Current Quarter | $1.55 | Next Quarter | $1.84 |
| Current Year | $5.85 | Next Year | $7.24 |
| QoQ Growth | +18.7% | YoY Growth | +23.8% |
| 3Y EPS CAGR | +7.0% | Target Price | $70.56 |
| Consensus | Buy | Upside | -9.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $77.50 | -1.0% | 1.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW